Company Profile
Updated: 04-JAN-10IMV Technologies S.A.
Non-Quoted Public Company
BP 81, 10 rue Georges Clemenceau, L'Aigle, F-61302 cedex, France
()33 02 33 34 64 64, 33 02 33 34 11 98 fax, http://www.imv-technologies.com
Primary SIC: Surgical And Medical Instruments, Primary NAICS: Surgical and Medical Instrument Manufacturing
Description: Manufacturing: Manufacture of animal reproduction technologies, including equipment for embryo transfer for numerous animal species, paying special attention to the needs of breeders and reproduction centers
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Immunovaccine Receives Clearance From FDA to Proceed With Phase 1 Clinical Trial for Its Therapeutic Cancer Vaccine.
Marketwire Canada; 12/9/2009; 1152 words; ...Chase, Immunovaccine's president and CEO. "DPX...tolerability of Immunovaccine's patented DepoVax(TM...TM), Immunovaccine's patented vaccine delivery...Immunovaccine Inc. (TSX VENTURE:IMV) is focused on the commercialization of its novel vaccine technology and product candidates...
Immunovaccine Licenses Vaccine Platform to Pfizer Animal Health.
Marketwire Canada; 11/23/2009; 1351 words; ...TSX VENTURE:IMV), a vaccine development...for Immunovaccine's patented vaccine delivery technology. Pfizer Animal Health...incorporating Immunovaccine's technology. Under...of Immunovaccine's platform lies in...TSX VENTURE:IMV) is a vaccine development...
Immunovaccine Inc. Signs Collaboration Agreement with National Cancer Institute.
Marketwire Canada; 11/10/2009; 1034 words; ...Inc. (TSX VENTURE:IMV), a vaccine development...involves formulating NCI's cancer vaccine antigens...TM), Immunovaccine's vaccine enhancement system...Inc. (TSX VENTURE:IMV) is focused on the commercialization of its novel vaccine technology and product candidates...
Immunovaccine Expands Collaboration with Defence Research & Development Canada.
Marketwire Canada; 10/29/2009; 1036 words; ...Inc. (TSX VENTURE:IMV), a vaccine development...that Immunovaccine's DepoVax(TM) technology can reduce the number...using the DepoVax(TM) technology. We are also expanding...Inc. (TSX VENTURE:IMV) is a vaccine development...
Immunovaccine Inc. Begins Trading on the TSX-V Under the Symbol "IMV".
Marketwire Canada; 10/5/2009; 821 words; ...Inc. (TSX VENTURE:IMV), formerly Rhino Resources...under the ticker symbol "IMV". "The start of trading...take our patented vaccine technology into Phase 1 human clinical...Rhino Resources Inc.'s (Rhino) Qualifying Transaction...resolution passed by Rhino's shareholders on September...
Recent News Articles
- Latest IMV CT Census Shows Slow-down in Expenditures for CT Technology.
Business Wire - March 24, 2008 - Latest IMV Market Report Shows Continued Investment in Cath Lab Technology.
Business Wire - January 08, 2007 - Latest IMV Market Report on U.S. Cath Lab Facilities Shows Digital Archiving Technology Used by 92% of Cath Labs.
Business Wire - September 07, 2004 - Latest IMV Market Report on U.S. Angio Lab Facilities Shows Evolving Technology and Procedure Utilization by Radiology.
Business Wire - July 03, 2003
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning